Acute Kidney Injury, Continuous Renal Replacement Therapy (CRRT), Electrolytes, ICU Patients
Conditions
Keywords
Regional Citrate Anticoagulation, Acute Kidney Injury, ICU patients, Continuous Renal Replacement Therapy, Diluted citrate, Electrolytes
Brief summary
The objective of this study is to evaluate the effectiveness of a modified continuous renal replacement therapy (CRRT) protocol in maintaining electrolyte balance in adult patients with acute kidney injury (AKI) admitted to the intensive care unit (ICU). The study assesses whether the use of continuous venovenous hemodiafiltration (CVVHDF) with post-filter replacement under citrate anticoagulation reduces electrolyte losses and the need for electrolyte supplementation compared with standard dialytic CRRT. Participants receiving standard CRRT will be compared with those treated with the modified protocol. The duration of participation corresponds to the period during which CRRT is required. Data collection will cease once CRRT is discontinued.
Detailed description
Electrolyte disturbances are common in patients undergoing continuous renal replacement therapy (CRRT) with regional citrate anticoagulation due to significant electrolyte losses during treatment. These alterations may lead to clinically relevant complications and increased need for electrolyte supplementation. This study evaluates a modified CRRT protocol combining diffusive and convective modalities with post-filter replacement, aiming to improve electrolyte balance and reduce electrolyte supplementation requirements. The primary objective is to assess whether continuous venovenous hemodiafiltration (CVVHDF) with post-filter replacement reduces the need for electrolyte supplementation compared with standard continuous venovenous hemodialysis (CVVHD) in patients with acute kidney injury. This is a non-randomized interventional study with sequential assignment comparing a prospective cohort treated with the modified CRRT protocol and a historical control cohort treated with standard dialytic CRRT. The study population includes adult patients (≥18 years) admitted to the multidisciplinary ICU of Hospital de la Santa Creu i Sant Pau with a diagnosis of acute kidney injury requiring CRRT.
Interventions
Continuous renal replacement therapy (CRRT) using regional citrate anticoagulation. Treatment modalities include continuous venovenous hemodialysis (CVVHD) and continuous venovenous hemodiafiltration (CVVHDF) with post-filter replacement, depending on study group assignment.
Sponsors
Study design
Intervention model description
This is a non-randomized interventional study with sequential assignment comparing a prospective cohort treated with a modified CRRT protocol including post-filter replacement with a historical control cohort treated with standard dialytic CRRT.
Eligibility
Inclusion criteria
* Age ≥18 years * Admission to the intensive care unit (ICU) * Diagnosis of acute kidney injury (AKI) requiring continuous renal replacement therapy (CRRT) * Use of regional citrate anticoagulation during CRRT
Exclusion criteria
* Known allergy or intolerance to citrate * Contraindications to citrate anticoagulation (e.g., severe liver failure or severe metabolic disorders affecting citrate metabolism) * Pregnancy or breastfeeding
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Total electrolyte supplementation during CRRT | From CRRT initiation through CRRT discontinuation, up to 14 days | Total amount of electrolyte supplementation administered during continuous renal replacement therapy (CRRT), including potassium, magnesium, and phosphate, expressed as total mmol administered per day (mmol/day) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| CRRT circuit lifespan (hours) | Assessed for each CRRT circuit from CRRT initiation through CRRT discontinuation, up to 7 days per circuit | Duration of each CRRT circuit, defined as the total time in hours that the extracorporeal circuit remains functional before replacement. |
Countries
Spain
Contacts
Fundació de Gestió Sanitarària de l'Hospital de la Santa Creu i Sant Pau de Barcelona